VR Logo

Earum Pharmaceuticals Ltd. download report


Healthcare | Drugs & Pharma

Earum Pharmaceuticals Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Earum Pharmaceuticals Ltd. Annual Report Earum Pharmaceuticals Ltd. chairman speech Earum Pharmaceuticals Ltd. director's report Earum Pharmaceuticals Ltd. management discussion Earum Pharmaceuticals Ltd. auditor's report Earum Pharmaceuticals Ltd. account notes
2020 Earum Pharmaceuticals Ltd. Annual Report Earum Pharmaceuticals Ltd. chairman speech Earum Pharmaceuticals Ltd. director's report Earum Pharmaceuticals Ltd. management discussion Earum Pharmaceuticals Ltd. corporate governance Earum Pharmaceuticals Ltd. auditor's report Earum Pharmaceuticals Ltd. account notes
2019 Earum Pharmaceuticals Ltd. Annual Report Earum Pharmaceuticals Ltd. chairman speech Earum Pharmaceuticals Ltd. director's report Earum Pharmaceuticals Ltd. management discussion Earum Pharmaceuticals Ltd. corporate governance Earum Pharmaceuticals Ltd. auditor's report Earum Pharmaceuticals Ltd. account notes

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 2012

Chairman: Bhumishth Narendrabhai Patel

Managing Director: Bhumishth Narendrabhai Patel

Listing: BSE: 542724

Country: India

Headquarters: Ahmedabad, Gujarat

Website: www.earumpharma.com

Key Facts

Market cap: ₹20.79 Cr

Revenue (TTM): ₹41.08 Cr

Earnings (TTM): ₹0.09 Cr

Cash: ₹0.06 Cr

Total Debt: ₹11.33 Cr

Promoters' ownership: 50.21%

Liquidity: Moderate

52 Week range: ₹3.34 - 26.40

Face value: ₹2.00

Shares outstanding: 6,16,79,100

6 Years Aggregate:

  • CFO: ₹-16.99 Cr
  • EBITDA: ₹-0.75 Cr
  • Net Profit: ₹4.74 Cr

Stock Performance

Time Period Earum Pharmaceuticals S&P BSE Healthcare S&P BSE Small Cap
YTD-66.63-17.55-15.86
1 month-28.90-3.85-3.26
3 months-40.67-11.97-10.93
1 Year-37.13-15.43-1.22
3 Years--18.7920.29
5 Years--9.0910.12
10 Years--12.1214.25
As on 30-Jun-2022